Nanosphere Health Sciences Inc(NSHSF)
USD --+0.00%
Reward63Moderate
Risk64Medium-High
📊75%Data
NSHSF
+0.0 · +0.00%
USD · PINK
Nanosphere Health Sciences Inc | Healthcare
Profitless Growth
Market Cap:446651
ℹ️
Reward Rating
63
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
64
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NSHSF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nanosphere Health Sciences Inc?

, a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

NSHSF · Verdict

Solid reward · elevated risk

NSHSF stands out on growth and volatility, but watch the cash flow signal.

Based on 88% data coverage

NSHSF · Verdict

What’s working & what to watch

Strengths 2

  • Growth87/100

    Top decile vs peers

  • Volatility65/100

    Above average

Watchouts 2

  • Cash flow5/100

    Weak vs peers

  • Profitability32/100

    0% return on equity

Model-based scoring. For information only — not financial advice.

What is Nanosphere Health Sciences Inc?

, a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 446.65K, and a P/E ratio of 0.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap446.65K
P/E Ratio0.3333
Dividend YieldN/A
52 Week High0.04
52 Week Low0.0038
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding10M
No. of EmployeesN/A
IndustryBiotechnology
ExchangePINK
Beta0.767
CurrencyUSD